Acquired by Thermo Fisher Scientific.
PharmaFluidics is a spin-off company of the Vrije Universiteit Brussel that developed a complementary range of reversed-phase chromatography columns for systems biology and biopharma applications.
QustomDot is developing cadmium-free quantum dots that are stable enough for advanced applications.
Flindr aims to restore a patient’s impaired immune response to cancer
THERAtRAME develops and positions new therapeutics targeting tRNA epitranscriptomics in cancer.